MARKER THERAPEUTICS, INC. (MRKR)

Import this data to Google Sheets with:

=jivedata("MRKR","financials")

Full statements spill as a table. For one cell: =jivedata("MRKR","Revenue") or =jivedata("MRKR","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

MARKER THERAPEUTICS, INC.

MRKR • CIK 0001094038

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Operating Income (Loss)	$-14,581.378	$-11,118.372	$-12,890.426	$-10,713.62
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	$-14,042.22	$-10,681.362	$-12,178.776	$-12,178.776
Income Tax Expense (Benefit)	$3.675	$49.953	$-15.156	$-15.156
Net Income (Loss) Attributable to Parent	$-8,236.814	$-10,731.315	$-12,163.62	$-8,707.379
Revenue from Contract with Customer, Including Assessed Tax	$3,311.133	$6,591.08	$3,546.669	$3,949.256
Research and Development Expense	$10,416.789	$13,467.845	$11,799.154	$8,805.561
General and Administrative Expense	$7,475.722	$4,241.607	$4,184.806	$4,244.44
Operating Expenses	$17,892.511	$17,709.452	$16,437.095	$13,050.001
Investment Income, Interest	$539.158	$437.01	$594.206	$549.138
Other Nonoperating Income	—	—	$117.444	$8.677
Weighted Average Number of Shares Outstanding, Basic	8,809,382	8,980,207	15,310,308	22,085,881

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Cash and Cash Equivalents, at Carrying Value	$15,111.45	$19,192.44	$16,068.048	$11,331.023
Restricted Cash, Current	—	—	$974.799	$591.309
Assets	$17,127.391	$22,022.86	$19,070.997	$14,585.485
Other Receivables, Net, Current	$1,027.815	$2,346.703	$1,369.4	$1,619.477
Liabilities	$3,074.848	$3,464.454	$2,274.183	$2,420.021
Accounts Payable and Accrued Liabilities, Current	$1,745.193	$1,753.954	$1,299.384	$1,023.917
Other Liabilities, Current	$1,329.655	$1,710.5	$1,710.5	$804.795
Common Stock, Value, Issued	$8.891	$10.708	$16.672	$16.672
Additional Paid in Capital	$450,329.515	$465,564.876	$475,960.94	$476,335.097
Retained Earnings (Accumulated Deficit)	$-436,285.863	$-447,017.178	$-459,180.798	$-464,186.305
Stockholders' Equity Attributable to Parent	$14,052.543	$18,558.406	$16,796.814	$12,165.464
Preferred Stock, Shares Authorized	5,000,000	5,000,000	5,000,000	5,000,000
Preferred Stock, Shares Issued	0	0	0	0
Common Stock, Shares Authorized	30,000,000	30,000,000	30,000,000	130,000,000
Common Stock, Shares, Issued	8,900,000	10,700,000	16,700,000	16,700,000

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$-8,236.814	$-10,731.315	$-12,163.62	$-8,707.379
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect	$3,329.278	$4,080.99	$-2,149.593	$107.386
Net Cash Provided by (Used in) Operating Activities	$-16,439.961	$-10,910.324	$-12,014.081	$-9,756.497
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$15,111.45	$19,192.44	$17,042.847	$18,988.294
Share-based Payment Arrangement, Noncash Expense	$858.269	$245.864	$537.54	$518.567
Proceeds from Issuance of Common Stock	$1,014.64	—	$9,863.883	$9,863.883
Net Cash Provided by (Used in) Financing Activities	$1,105.117	$14,991.314	$9,864.488	$9,864.488
Increase (Decrease) in Other Receivables	—	—	$-977.303	$-54.858
Increase (Decrease) in Due to Related Parties, Current	—	$380.845	$-1,710.5	$148.164
Increase (Decrease) in Accounts Payable and Accrued Liabilities	$611.262	$8.761	$-454.57	$-1,243.954
Increase (Decrease) in Deferred Revenue	$-1,146.186	—	$974.799	$974.799

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("MRKR","financials")

Full statements spill as a table. For one cell: =jivedata("MRKR","Revenue") or =jivedata("MRKR","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.